Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-6 receptor subunit beta (IL6RB), also known as gp130, is a critical signal-transducing component shared by several cytokine receptors, including the receptor for interleukin-6 (IL-6). Upon ligand binding, gp130 dimerizes and activates downstream JAK/STAT and MAPK pathways, leading to diverse biological effects. Dysregulation of the IL-6/gp130 pathway is implicated in various diseases, making it a therapeutic target.
Selective antagonists targeting the IL-6/gp130 pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-6 Receptor Subunit Beta (IL6RB).